drugset / Trial / NCT06884098
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
RandomizedCrossoverOpen-labelTreatment
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Timeline
- Start
- 2025-03-10
- Primary completion
- 2025-04
- Completion
- 2025-04